Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II StudyAndrea Necchi, Andrea Anichini, Daniele Raggi, et al.European Urology Oncology|May 18, 2020
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 StudyAndrea Necchi, Daniele Raggi, Patrizia Giannatempo, et al.World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.Journal of the National Cancer Institute|June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder CancerMarco Bandini, Jeffrey S Ross, Daniele Raggi, et al.European Urology|November 12, 2019
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant HistologiesAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.Clinical Genitourinary Cancer|March 8, 2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional StudyMarco Bandini, Filippo Pederzoli, Russell Madison, et al.European Radiology Experimental|November 16, 2025
Intra- and inter-tumoural heterogeneity in von Hippel-Lindau disease-related renal cancer: a multimodal data study protocolIsaline Rowe, Alberto Colombo, Francesca Corea, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.European Urology|December 29, 2019
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 StudyAndrea Necchi, Marco Bandini, Giuseppina Calareso, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2021
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional ExperienceMaria Del Carmen Rodriguez Pena, Sofia Canete-Portillo, Ali Amin, et al.Pageof 8